Stocks and Investing Stocks and Investing
Fri, February 7, 2020
Thu, February 6, 2020

Alethia Young Reiterated (BIIB) at Hold with Increased Target to $361 on, Feb 6th, 2020


Published on 2024-10-26 21:32:13 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Reiterated "Biogen Inc." (BIIB) at Hold with Increased Target from $315 to $361 on, Feb 6th, 2020.

Alethia has made no other calls on BIIB in the last 4 months.



There are 8 other peers that have a rating on BIIB. Out of the 8 peers that are also analyzing BIIB, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $297 on, Wednesday, October 23rd, 2019


These are the ratings of the 6 analyists that currently disagree with Alethia


  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Increased Target to $360 on, Monday, February 3rd, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Held Target at $360 on, Monday, January 27th, 2020
  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
  • Adnan Butt of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, October 23rd, 2019
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $335 on, Wednesday, October 23rd, 2019
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $325 on, Wednesday, October 23rd, 2019
Contributing Sources